Dr. Omid Hamid MD of the Chief, Translational Research & Immuno-OncologyÂ
Director, Cutaneous Malignancies, The Angeles Clinic and Research Institute discusses how Immuno-Oncology will affect not only melanoma but many other disease states within oncology.